Abstract

BackgroundHip involvement is considered an important prognostic factor associated with radiographic progression in ankylosing spondylitis (AS) patients. However, there are no studies regarding hip involvement impact on clinical response and...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Gender Differences in Ankylosing Spondylitis Patients with Advanced Hip Involvement: Results from A Matched Retrospective Cohort Study
Ming Ni ... Liang‐Liang Li
Orthopaedic Surgery | VOL. 14
Ming Ni, et. al.Ming Ni ... Liang‐Liang Li
13 Dec 2021
Cigarette Smoking Increases the Prevalence of Hip Joint Involvement in Ankylosing Spondylitis: A Real-World Case-Control Study.
Jian Zhu ... Jianglin Zhang
The Journal of rheumatology | VOL. 50
Jian Zhu, et. al.Jian Zhu ... Jianglin Zhang
15 Jan 2023
AB0793 Clinical Characteristics of Hip Arthritis in Patients with Ankylosing Spondylitis in Korea
H.-S Cha ... J Hwang
Annals of the Rheumatic Diseases | VOL. 74
H.-S Cha, et. al.H.-S Cha ... J Hwang
01 Jun 2015
THU0279 Absence of radiographic progression of hip arthritis in patients with ankylosing spondylitis treated with infliximab for 6 years
A Iliopoulos ... V.K Bournia
Annals of the Rheumatic Diseases | VOL. 71
A Iliopoulos, et. al.A Iliopoulos ... V.K Bournia
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers